Company / Shares Outstanding
BeOne Medicines Ltd. Shares Outstanding History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shares Outstanding
1.4B
FY2025
5-year range
1.2B / 1.4B
FY2021-FY2025
Trend
+2.0%
vs FY2024
Sector context
#7 of 212
Health Care
What the data says
Among 212 Health Care companies, BeOne Medicines Ltd. is in the bottom 3% for shares outstanding. Shares Outstanding has increased for 9 consecutive years, from 116174094.00 in FY2016 to 1387367704.00 in FY2025.
Based on SEC 10-K filings.
1387367704.00 in FY2025 with a 5-year CAGR of +11.6%. Top quartile in the Health Care sector.
Increased from 1356140180.00 to 1387367704.00 over the past 2 years.
Health Care sector context is included.
Shares Outstanding over time
Growth rates
- 3-Year CAGR
- +1.3%
- 5-Year CAGR
- +11.6%
- 10-Year CAGR
- -
Sector benchmark
+353.4% above sector average
Key checks
Key Insights
- BeOne Medicines Ltd.'s shares outstanding has grown for 9 consecutive years.
- In FY2025, shares outstanding increased 2.0% year-over-year.
- Ranks #7 out of 212 companies in the Health Care sector.
- Lowest shares outstanding in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 0.82 (distress zone, below 1.8 threshold)
- Negative profit margin: -16.9%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shares OutstandingValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 1.4B | +2.0% |
| FY2024 | 1.4B | +0.2% |
| FY2023 | 1.4B | +1.6% |
| FY2022 | 1.3B | +10.7% |
| FY2021 | 1.2B | +50.5% |
| FY2020 | 801.3M | +3.2% |
| FY2019 | 776.3M | +31.1% |
| FY2018 | 592.1M | +14.8% |
| FY2017 | 515.8M | +344.0% |
| FY2016 | 116.2M | +5.0% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026